BMJ  2006;333:212-213 (29 July), doi:10.1136/bmj.333.7561.212

Editorial

Psychological and social interventions for schizophrenia

Robust evidence supports a wide range, including cognitive therapy

The first 150 words of the full text of this article appear below.

Over the past two decades few disorders have been subject to such big changes in management as schizophrenia. Yet these have gone unnoticed by the general medical and popular press—possibly because these changes have not arisen from breakthroughs in research on genetics, receptors, anatomy, or neuropharmacology.

The new generation of antipsychotic drugs has not fulfilled its promise of substantially increased effectiveness or even of much better tolerability.1 In this week's BMJ Tiihonen and colleagues show that, in practice, some older drugs such as perphenazine are as efficacious as the newer ones.2 This follows the findings of the National Institute of Mental Health clinical antipsychotic trials of intervention effectiveness (CATIE) study that 74% of patients with established symptoms of schizophrenia discontinued their medication within 18 months and there was no overall difference in effect between perphenazine and the newer atypical drugs.1 3 When patients can accept and tolerate clozapine, this does . . . [Full text of this article]

David Kingdon, professor of mental health care delivery

University of Southampton, Department of Psychiatry, Royal South Hants Hospital, Southampton SO14 0YG
(dgk@soton.ac.uk)


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Articles

What works in schizophrenia: Cognitive behaviour therapy is not effective
Peter J McKenna
BMJ 2006 333: 353. [Extract] [Full Text]

Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study
Jari Tiihonen, Kristian Walhbeck, Jouko Lönnqvist, Timo Klaukka, John P A Ioannidis, Jan Volavka, and Jari Haukka
BMJ 2006 333: 224. [Abstract] [Full Text] [PDF]

Are older antipsychotic drugs obsolete?
Rohan Ganguli and Martin Strassnig
BMJ 2006 332: 1346-1347. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • KINGDON, D., YOUNG, A. H. (2007). Research into putative biological mechanisms of mental disorders has been of no value to clinical psychiatry. Br. J. Psychiatry 191: 285-290 [Full text]  
  • McKenna, P. J (2006). What works in schizophrenia: Cognitive behaviour therapy is not effective. BMJ 333: 353-353 [Full text]  

Rapid Responses:

Read all Rapid Responses

Schizophrenia - prodromal symptoms and the clinical dilemma.
Arnob Chakraborti
bmj.com, 28 Jul 2006 [Full text]
Community psychiatric care is not a solution for all
Katharine E Nolan
bmj.com, 30 Jul 2006 [Full text]
Schizophrenia: Cautious Optimism in Service Provision
v Balasubramanian, et al.
bmj.com, 1 Aug 2006 [Full text]
One psychological intervention is not effective in schizophrenia
Peter J McKenna
bmj.com, 2 Aug 2006 [Full text]
Neither Isolationism Nor Interventionism Can Be The Answer
Dr. Herbert H. Nehrlich
bmj.com, 4 Aug 2006 [Full text]
Quo vadis, Domine? Re: One psychological intervention is not effective in schizophrenia
Adrian Blaj
bmj.com, 4 Aug 2006 [Full text]
CBTP is not the only answer but it probably forms part of it
David Kingdon
bmj.com, 6 Aug 2006 [Full text]
The cost of atypical antipsychotic treatments:
Walid K. Abdul-Hamid
bmj.com, 10 Aug 2006 [Full text]
Future of cognitive behavioural therapy in chronic psychosis
Tanushree Sarma
bmj.com, 2 Feb 2007 [Full text]
Different Treatments for Different Symptoms
Mark Agius, et al.
bmj.com, 26 Feb 2007 [Full text]



Student BMJ

Risk of surgery for inflammatory bowel disease: record linkage studies

What can you learn from this BMJ paper? Read Leanne Tite's Paper+

www.student.bmj.com

Listen to the latest BMJ Interview